Literature DB >> 27413309

Seroepidemiological study of toxoplasmosis in southern districts of Tamil Nadu.

G Sucilathangam1, T Anna2.   

Abstract

The current study was conducted with the objectives of estimating the seroprevalence of Toxoplasma gondii and associated socio-demographic, clinical and behavioural characteristics in and around Tirunelveli. Serum samples from 175 immunodeficient and 175 immunocompetent patients were collected and were analyzed by in-house enzyme linked immunosorbent assay (ELISA). A questionnaire survey was administered for all study participants to gather information on risk factors. The present study revealed that anti- T. gondii IgG antibodies were detected in 13.14 % which constitutes 15.43 % in immunocompromised and 10.86 % in immunocompetent patients. There was a significant difference between sex of the study population and drinking water source. Seroprevalence was increased in the male (19.12 %, p = 0.0075, OR 2.316, 95 % CI 1.2362-4.3405) than the female and with river water consumption other than bore water (12.5 %, p = 0.0483, OR 0.857, 95 % CI 0.1853-3.4641). No significant relations were observed between anti-Toxoplasma IgG antibodies and age, residence, diet and animal contact in the study population. Toxoplasmosis will remain a problem, mainly in risk groups such as pregnant women and immunocompromised patients. Improvement can only be attained by increasing prevention and reducing the risk factors.

Entities:  

Keywords:  Enzyme-linked Immunosorbent assay (ELISA); Risk factors; Seroprevalence; Tamil Nadu; Toxoplasma gondii

Year:  2014        PMID: 27413309      PMCID: PMC4927496          DOI: 10.1007/s12639-014-0514-7

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  20 in total

1.  Seroprevalence of toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India.

Authors:  Brogen Singh Akoijam; Sarman Singh; S K Kapoor
Journal:  J Indian Med Assoc       Date:  2002-10

2.  Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of Sao Tome and Principe.

Authors:  Chien-Ching Hung; Chia-Kwung Fan; Kua-Eyre Su; Fung-Chang Sung; Hung-Yi Chiou; Vilfrido Gil; Maria da Conceicao dos Reis Ferreira; Jose Manuel de Carvalho; Claudina Cruz; Yu-Kuan Lin; Lian-Fen Tseng; Ke-Yun Sao; Wen-Cheun Chang; Hung-Shue Lan; Shing-Hsien Chou
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-11-17       Impact factor: 2.184

3.  Prevalence of torch infections in Indian pregnant women.

Authors:  S Singh
Journal:  Indian J Med Microbiol       Date:  2002 Jan-Mar       Impact factor: 0.985

4.  Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis.

Authors:  A E Ades; S Parker; R Gilbert; P A Tookey; T Berry; M Hjelm; A H Wilcox; D Cubitt; C S Peckham
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

5.  Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii.

Authors:  J Flegr; S Zitková; P Kodym; D Frynta
Journal:  Parasitology       Date:  1996-07       Impact factor: 3.234

6.  Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia.

Authors:  B Bobić; I Jevremović; J Marinković; D Sibalić; O Djurković-Djaković
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

8.  Toxoplasma seroprevalence in healthy voluntary blood donors from urban Karnataka.

Authors:  P Sundar; A Mahadevan; R S Jayshree; D K Subbakrishna; S K Shankar
Journal:  Indian J Med Res       Date:  2007-07       Impact factor: 2.375

Review 9.  A brief history and overview of Toxoplasma gondii.

Authors:  E A Innes
Journal:  Zoonoses Public Health       Date:  2009-09-10       Impact factor: 2.702

10.  Serological survey of toxoplasmosis in a district in Tamil Nadu: hospital-based study.

Authors:  G Sucilathangam; N Palaniappan; C Sreekumar; T Anna
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.